Browse by all authors Browse By Author Name - Morey,+Adrienne

Browse Results (9 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Bilous, Michael, Morey, Adrienne, Armes, Jane, Cummings, Margaret and Francis, Glenn (2006) Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry. Pathology, 38 2: 120-124. doi:10.1080/00313020600561518 198   31 Cited 31 times in Scopus31 0
Chou, Angela, Waddell, Nicola, Cowley, Mark J., Gill, Anthony J., Chang, David K., Patch, Ann-Marie, Nones, Katia, Wu, Jianmin, Pinese, Mark, Johns, Amber L., Miller, David K., Kassahn, Karin S., Nagrial, Adnan M., Wasan, Harpreet, Goldstein, David, Toon, Christopher W., Chin, Venessa, Chantrill, Lorraine, Humphris, Jeremy, Mead, R. Scott, Rooman, Ilse, Samra, Jaswinder S., Pajic, Marina, Musgrove, Elizabeth A., Pearson, John V., Morey, Adrienne L., Grimmond, Sean M. and Biankin, Andrew V. (2013) Clinical and molecular characterization of HER2 amplified-pancreatic cancer. Genome Medicine, 5 8: 78.1-78.10. doi:10.1186/gm482 27   8 Cited 6 times in Scopus6 81
Farshid, Gelareh, Armes, Jane E., Bell, Richard, Cummings, Margaret, Fox, Stephen, Francis, Glenn, Haswell, Martin, Morey, Adrienne, McCue, Glenda, Raymond, Wendy, Robbins, Peter and Bilous, Michael (2010) Establishment of the Australian in situ hybridization program for the assessment of HER2 amplification in breast cancer: A model for the introduction of new biomarkers into clinical practice. Diagnostic Molecular Pathology, 19 4: 187-193. doi:10.1097/PDM.0b013e3181e1cc9d 5   4 Cited 4 times in Scopus4 0
Fox, Stephen B., Kumarasinghe, Marian Priyanthi, Armes, Jane E., Bilous, Michael, Cummings, Margaret C., Farshid, Gelareh, Fitzpatrick, Nicole, Francis, Glenn D., McCloud, Philip I., Raymond, Wendy and Morey, Adrienne (2012) Gastric HER2 testing study (GaTHER): An evaluation of gastric/ gastroesophageal junction cancer testing accuracy in Australia. American Journal of Surgical Pathology, 36 4: 577-582. doi:10.1097/PAS.0b013e318244adbb 65   14 Cited 14 times in Scopus14 1
Mallon, Patrick W. G., Unemori, Patrick, Sedwell, Rebecca, Morey, Adrienne, Rafferty, Martina, Williams, Kenneth, Chisholm, Donald, Samaras, Katherine, Emery, Sean, Kelleher, Anthony, Cooper, David A. and Carr, Andrew (2005) In vivo, nucleoside reverse‐transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA. The Journal of Infectious Diseases, 191 10: 1686-1696. doi:10.1086/429697 53   Cited 126 times in Scopus126 0
Cummings, Margaret C., Simpson, Peter T., Reid, Lynne E., Jayanthan, Janani, Skerman, Joanna, Song, Sarah, McCart Reed, Amy E., Kutasovic, Jamie R., Morey, Adrienne L., Marquart, Louise, O'Rourke, Peter and Lakhani, Sunil R. (2014) Metastatic progression of breast cancer: Insights from 50 years of autopsies. Journal of Pathology, 232 1: 23-31. doi:10.1002/path.4288 53   3 Cited 7 times in Scopus7 6
Cooper, Wendy, Fox, Stephen, O'Toole, Sandra, Morey, Adrienne, Frances, Glenn, Pavlakis, Nick, O'Byrne, Kenneth, Dettrick, Andrew, Leong, Trishe, Rathi, Vivek, Spagnolo, Dominic, Hemmings, Chris, Singh, Mahendra, Moffat, David, Tsao, Ming-Sound, Wilner, Keith, Buller, Richard, Pitman Lowenthal, Susan, Arifeen, Shams, Binko, Justin and Alam, Mahmood (2014) National Working Group Meeting on ALK diagnostics in lung cancer. Asia-Pacific Journal of Clinical Oncology, 10 Supp. 2: 11-17. doi:10.1111/ajco.12190 28   1 Cited 1 times in Scopus1 0
Webster, Lucy R., Lee, Shu-Fen, Ringland, Clare, Morey, Adrienne L., Hanby, Andrew M., Morgan, Graeme, Byth, Karen, Mote, Patricia A., Provan, Pamela J., Ellis, Ian O., Green, Andrew R., Lamoury, Gillian, Ravdin, Peter, Clarke, Christine L., Ward, Robyn L., Balleine, Rosemary L. and Hawkins, Nicholas J. (2008) Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification. Clinical Cancer Research, 14 20: 6625-6633. doi:10.1158/1078-0432.CCR-08-0701 4   8 Cited 9 times in Scopus9 0
Webster, Lucy R., Provan, Pamela J., Graham, Dinny J., Byth, Karen, Walker, Robert L., Davis, Sean, Salisbury, Elizabeth L., Morey, Adrienne L., Ward, Robyn L., Hawkins, Nicholas J., Clarke, Christine L., Meltzer, Paul S. and Balleine, Rosemary L. (2013) Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33. Pathology, 45 7: 629-636. doi:10.1097/PAT.0000000000000004 6   0 Cited 0 times in Scopus0 1